Jaksil, Kadil .
HRN: 14-09-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2023
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
01/28/2023
01/31/2023
ORAL
5 Ml
12 Hrs
Intestinal Ascariasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes